Peoples Bank KS Has $1.02 Million Holdings in CVS Health Co. (NYSE:CVS)

Peoples Bank KS cut its holdings in CVS Health Co. (NYSE:CVS) by 44.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,273 shares of the pharmacy operator’s stock after selling 13,069 shares during the period. Peoples Bank KS’s holdings in CVS Health were worth $1,023,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. LifePlan Financial LLC increased its stake in CVS Health by 12.1% in the 3rd quarter. LifePlan Financial LLC now owns 21,937 shares of the pharmacy operator’s stock valued at $1,379,000 after buying an additional 2,375 shares during the last quarter. Apella Capital LLC purchased a new position in CVS Health in the third quarter worth $249,000. Alpha Omega Wealth Management LLC grew its stake in CVS Health by 1.3% in the 3rd quarter. Alpha Omega Wealth Management LLC now owns 153,687 shares of the pharmacy operator’s stock valued at $9,664,000 after purchasing an additional 1,969 shares during the period. Farmers Trust Co. increased its position in shares of CVS Health by 7.6% during the 3rd quarter. Farmers Trust Co. now owns 79,493 shares of the pharmacy operator’s stock valued at $4,999,000 after purchasing an additional 5,634 shares during the last quarter. Finally, Czech National Bank boosted its holdings in shares of CVS Health by 7.2% in the 3rd quarter. Czech National Bank now owns 256,430 shares of the pharmacy operator’s stock worth $16,124,000 after buying an additional 17,206 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Trading Up 2.7 %

Shares of NYSE CVS traded up $1.67 during trading hours on Friday, hitting $64.59. The company’s stock had a trading volume of 16,310,789 shares, compared to its average volume of 11,032,696. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. The business has a 50-day simple moving average of $58.52 and a 200-day simple moving average of $61.67. The stock has a market cap of $81.08 billion, a price-to-earnings ratio of 11.06, a P/E/G ratio of 0.81 and a beta of 0.54.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping the consensus estimate of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The business had revenue of $91.23 billion during the quarter, compared to analyst estimates of $91.41 billion. During the same period in the prior year, the business earned $2.21 EPS. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. On average, analysts anticipate that CVS Health Co. will post 6.51 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be issued a dividend of $0.665 per share. The ex-dividend date of this dividend is Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.12%. CVS Health’s payout ratio is 46.75%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on CVS. Royal Bank of Canada reiterated an “outperform” rating and issued a $68.00 target price on shares of CVS Health in a research note on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft cut their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Wells Fargo & Company upped their price objective on shares of CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a report on Monday, August 12th. Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a research note on Tuesday. Finally, Barclays cut their price objective on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating for the company in a research report on Thursday, August 8th. Ten equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $73.40.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.